LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 962 | 8562 | 10692 | 0.8008 | 0.8761 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 962 | 8010 | 10692 | 0.7492 | 0.8403 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 962 | 8142 | 10692 | 0.7615 | 0.8490 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 72 | hr | 962 | 7685 | 10692 | 0.7188 | 0.8186 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10729 | 10512 | 1.0209 | 1.0120 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10395 | 10512 | 0.9892 | 0.9937 |
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9986 | 10512 | 0.9501 | 0.9705 |
MCF 10A | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 9492 | 10512 | 0.9033 | 0.9418 |
MCF 10A | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 9064 | 10512 | 0.8625 | 0.9159 |
MCF 10A | Linsitinib | 10 | uM | LJP5 | 72 | hr | 962 | 8613 | 10512 | 0.8197 | 0.8879 |
MCF 10A | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10310 | 10512 | 0.9808 | 0.9888 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10299 | 10512 | 0.9798 | 0.9882 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 10167 | 10512 | 0.9673 | 0.9808 |
MCF 10A | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 9887 | 10512 | 0.9407 | 0.9649 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 9673 | 10512 | 0.9206 | 0.9524 |
MCF 10A | Ruxolitinib | 10 | uM | LJP5 | 72 | hr | 962 | 7375 | 10512 | 0.7018 | 0.8047 |
MCF 10A | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10172 | 10512 | 0.9679 | 0.9811 |
MCF 10A | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9634 | 10512 | 0.9168 | 0.9503 |
MCF 10A | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8778 | 10512 | 0.8352 | 0.8983 |
MCF 10A | Momelotinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 7297 | 10512 | 0.6944 | 0.7993 |
MCF 10A | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 4396 | 10512 | 0.4184 | 0.5535 |
MCF 10A | Momelotinib | 10 | uM | LJP5 | 72 | hr | 962 | 1247 | 10512 | 0.1187 | 0.0779 |
MCF 10A | Fedratinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 9927 | 10512 | 0.9446 | 0.9671 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9510 | 10512 | 0.9048 | 0.9427 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8912 | 10512 | 0.8478 | 0.9062 |